Enhancement of radiation effects in vitro by the estrogen metabolite 2- methoxyestradiol

Radiation Research

Volumn 153, Issue 4, 2000, Pages 384-391

  Amorino, George P ^a,b   Freeman, Michael L ^a   Choy, Hak ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; ESTRADIOL;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOTOXICITY; ESTROGEN THERAPY; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY;

MINK CELL FOCUS-FORMING VIRUS; MURINAE; TRIXIS;

EID: 0034029083     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2000)153[0384:EOREIV]2.0.CO;2     Document Type: Article

References (36)

1. N. Klauber, S. Parangi, E. Flynn, E. Hamel and R. J. D'Amato, Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res. 57, 81-86 (1997).
2. T. Fotsis, Y. Shang, M. S. Pepper, H. Adlercreutz, R. Montesano, P. P. Nawroth and L. Schweigerer, The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368, 237-239 (1994).
3. T. L. Yue, X. Wang, C. S. Louden, S. Gupta, K. Pillarisetti, J. L. Gu, T. K. Hart, P. G. Lysko and G. Z. Feuerstein, 2-methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein kinase signaling pathway and Fas expression. Mol. Pharmacol. 51, 951-962 (1997).
4. A. Tsukamoto, Y. Kaneko, T. Yoshida, K. Han, M. Ichinose and S. Kimura, 2-Methoxyestradiol, an endogenous metabolite of estrogen, enhances apoptosis and beta-galactosidase expression in vascular endothelial cells. Biochem. Biophys. Res. Commun. 248, 9-12 (1998).
5. T. Mukhopadhyay and J. A. Roth, Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol. Oncogene 14, 379-384 (1997).
6. R. J. D'Amato, C. M. Lin, E. Flynn, J. Folkman and E. Hamel, 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc. Natl. Acad. Sci. USA 91, 3964-3968 (1994).
7. E. Aizu-Yokota, A. Susaki and Y. Sato, Natural estrogens induce modulation of microtubules in Chinese hamster V79 cells in culture. Cancer Res. 55, 1863-1868 (1995).
8. P. B. Schiff, J. Fant and S. B. Horwitz, Promotion of microtubule assembly in vitro by taxol. Nature 277, 665-667 (1979).
9. H. Choy, F. F. Rodriguez, S. Koester, S. Hilsenbeck and D. D. Von Hoff, Investigation of Taxol as a potential radiation sensitizer. Cancer 71, 3774-3778 (1993).
10. J. C. Seegers, M. L. Lottering, C. J. Grobler, D. H. vanPapendorp, R. C. Habbersett, Y. Shou and B. E. Lehnert, The mammalian metabolite, 2-methoxyestradiol, affects p53 levels and apoptosis induction in transformed cells but not in normal cells. J. Steroid Biochem. Mol. Biol. 62, 253-267 (1997).
11. H. Attalla, T. P. Makela, H. Adlercreutz and L. C. Andersson, 2-Methoxyestradiol arrests cells in mitosis without depolymerizing tubulin. Biochem. Biophys Res. Commun. 228, 467-473 (1996).
12. 2 irradiation. Cancer Genet. Cytogenet. 108, 38-41 (1999).
13. 2 cell cycle period. Cancer Res. 44, 5577-5582 (1984).
14. J. Bussink, P. J. Tofilon and W. A. Brock, Repair of chromosome and DNA breaks versus cell survival in Chinese hamster cells. Int. J. Radiat. Biol. 70, 23-32 (1996).
15. G. Iliakis and M. Nusse, Evidence that repair and expression of potentially lethal damage cause the variations in cell survival after X irradiation observed through the cell cycle in Ehrlich ascites tumor cells. Radiat. Res. 95, 87-107 (1983).
16. L. F. Winans, W. C. Dewey and C. M. Dettor, Repair of sublethal and potentially lethal X-ray damage in synchronous Chinese hamster cells. Radiat. Res. 52, 333-351 (1972).
17. H. Choy, L. Yee and B. F. Cole, Combined-modality therapy for advanced non-small cell lung cancer: paclitaxel and thoracic irradiation. Semin. Oncol. 22 (Suppl. 15), 38-44 (1995).
18. C. U. Kirchgessner, C. K. Patil, J. W. Evans, C. A. Cuomo, L. M. Fried, T. Carter, M. A. Oettinger and J. M. Brown, DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science 267, 1178-1182 (1995).
19. G. P. Amorino and R. L. Hoover, Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production. Am. J. Pathol. 152, 199-207 (1998).
20. W. K. Sinclair and R. A. Morton, X-ray and ultraviolet sensitivity of synchronized Chinese hamster cells at various stages of the cell cycle. Biophys. J. 5, 1-12 (1965).
21. M. M. Elkind and G. F. Whitmore, The Radiobiology of Cultured Mammalian Cells, pp. 20-26. Gordon and Breach, New York, 1967.
22. G. G. Steel and M. J. Peckham, Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int. J. Radiat. Oncol. Biol. Phys. 5, 85-91 (1979).
23. A. H. W. Nias, An Introduction to Radiobiology, pp. 169-171. Wiley, Chichester, 1990.
24. A. Krishan, Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 66, 188-193 (1975).
25. B. Nevaldine, J. A. Longo and P. J. Hahn, The seid defect results in much slower repair of DNA double-strand breaks but not high levels of residual breaks. Radiat. Res. 147, 535-540 (1997).
26. D. E. Wazer, M. Joyce, G. Solares and R. Schmidt-Ullrich, Proliferative inhibition of human breast carcinoma cells by high concentration estradiol does not alter radiosensitivity. Breast Cancer Res. Treat. 18, 141-148 (1991).
27. D. Yoshida, J. Piepmeier and M. Weinstein, Estramustine sensitizes human glioblastoma cells to irradiation. Cancer Res. 54, 1415-1417 (1994).
28. R. J. Cummins, C. Mothersill, C. B. Seymour, H. Johns and M. C. Joiner, The effect of microcolony size, at time of irradiation, on colony forming ability. Int. J. Radiat. Biol. 75, 225-232 (1999).
29. R. B. Tishler, C. R. Geard, E. J. Hall and P. B. Schiff, Taxol sensitizes human astrocytoma cells to radiation. Cancer Res. 52, 3495-3497 (1992).
30. W. K. Sinclair and R. A. Morton, X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells. Radiat. Res. 29, 450-474 (1966).
31. T. Terasima and L. J. Tolmach, X-ray sensitivity and DNA synthesis in synchronous populations of HeLa cells. Science 140, 490-492 (1963).
32. F. Reiser, D. Way, M. Bermas, M. Witte and C. Witte, Inhibition of normal and experimental angiotumor endothelial cell proliferation and cell cycle progression by 2-methoxyestradiol. Proc. Soc. Exp. Biol. Med. 219, 211-216 (1998).
33. S. Ryu, M. Gabel, M. S. Khil, Y. J. Lee, S. Kim and J. H. Kim, Estramustine: a novel radiation enhancer in human carcinoma cells. Int. J. Radiat. Oncol. Biol. Phys. 30, 99-104 (1994).
34. M. E. Stearns, M. Wang, K. D. Tew and L. I. Binder, Estramustine binds a MAP-1-like protein to inhibit microtubule assembly in vitro and disrupt microtubule organization in DU 145 cells. J. Cell Biol. 107, 2647-2656 (1988).
35. E. J. Hall, Radiobiology for the Radiologist, 3rd ed., p. 112. J. B. Lippincott, Philadelphia, 1988.
36. M. Ikebuchi and H. Kimura, Recovery from sublethal damage is reversibly inhibited by hypertonic saline: the effects of 0.23 M sodium chloride. Radiat. Res. 150, 416-422 (1998).